<?xml version="1.0" encoding="utf-8"?>
 <journal>
 <language></language>
 <journal_id_issn>1561-4921</journal_id_issn>
 <journal_id_issn_online>1735-8086</journal_id_issn_online>
 <journal_id_pubmed></journal_id_pubmed>
 <journal_id_pii></journal_id_pii>
 <journal_id_doi></journal_id_doi>
 <journal_id_isnet></journal_id_isnet>
 <journal_id_iranmedex></journal_id_iranmedex>
 <journal_id_magiran></journal_id_magiran>
 <journal_id_sid></journal_id_sid>

 <pubdate>
	<type>jalali</type>
	<year>1387</year>
	<month>10</month>
	<day>12</day>
 </pubdate>
 <pubdate>
	<type>gregorian</type>
	<year>2009</year>
	<month>1</month>
	<day>1</day>
 </pubdate>
 <volume>1</volume>
 <number>41</number>

 <publish_type>online</publish_type>
 <publish_edition>1</publish_edition>
 <article_type>fulltext</article_type>

<articleset>
	<article>
	<language></language>
	<article_id_issn>1561-4921</article_id_issn>
	<article_id_issn_online>1735-8086</article_id_issn_online>
	<article_id_pubmed></article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_isnet></article_id_isnet>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	
	<title_fa></title_fa>
	<title>Effects of Different Doses of Bone Morphogenetic Protein 4 on Viability and Proliferation Rates of Mouse Embryonic Stem Cells </title>
	<subject_fa/>
	<subject/>
	
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	
	
	<abstract_fa></abstract_fa>
	<abstract> Objective: In this study, we examined the effect of different doses of bone morphogenetic protein 4 (BMP4) on CCE mouse embryonic stem cells (ESCs) viability and proliferation rates in order to improve the outcome of induction processes and make a system with highest viability and proliferation rates for further studies on BMP4 roles in multiple developmental stages. Materials and Methods: Expression of Oct-4 was studied and confirmed in this cell line immunocytochemically. Also, in order to evaluate the proliferation and viability rates in BMP4-treated cells, ESCs were cultured in Dulbecco's Modified Eagle Medium (DMEM) containing different doses of BMP4 (0, 0.01, 0.1, 1, 5, 25, 50 and 100ng/ml). The mean number of whole cells and living cells were considered as proliferation and survival rates respectively. Data analysis was done with ANOVA test. Results: The results showed that there were significant differences between the mean percent of viability between 1ng/ml and 0 ng/ml (control) and 50 and 100 ng/ml BMP4 (p≤0.01), as well as between 5 ng/ml and 0, 0.01, 0.1, 25, 50 and 100 ng/ml BMP4 (p≤ 0.02). Also, significant differences were observed in proliferation rates between 5 ng/ml and 0, 0.01, 0.1, 1, 25 and 100 ng/ml BMP4 (p≤0.01), 25 ng/ml and 0.01, 1 and 5 ng/ml BMP4 (p≤0.01), as well as between 50 ng/ml and 0.01 and 0.1 ng/ml BMP4 (p≤0.001). Conclusion: The results suggest that addition of 5ng/ml BMP4 had the best effects on the proliferation and viability rates of CCE mouse ESCs. </abstract>

	<keyword_fa></keyword_fa>
	<keyword>Embryonic Stem Cells, BMP4, Proliferation, Viability </keyword>
	<start_page>0</start_page>
	<end_page>0</end_page>
	<web_url></web_url>
	<web_url></web_url>
	<author_list>
	<author>
		<first_name></first_name>
		<middle_name/>
		<last_name></last_name>
		<suffix/>
		<affiliation></affiliation>
		<first_name_fa>Mansoureh Movahedin</first_name_fa>
		<middle_name_fa></middle_name_fa>
		<last_name_fa></last_name_fa>
		<suffix_fa/>
		<email>mansoure@modares.ac.ir</email>
		<code></code>
		<coreauthor>No</coreauthor>
		<affiliation_fa></affiliation_fa>
	</author>
	<author>
		<first_name></first_name>
		<middle_name/>
		<last_name></last_name>
		<suffix/>
		<affiliation></affiliation>
		<first_name_fa>Zohreh Makoolati</first_name_fa>
		<middle_name_fa></middle_name_fa>
		<last_name_fa></last_name_fa>
		<suffix_fa/>
		<email></email>
		<code></code>
		<coreauthor>No</coreauthor>
		<affiliation_fa></affiliation_fa>
	</author>
	<author>
		<first_name></first_name>
		<middle_name/>
		<last_name></last_name>
		<suffix/>
		<affiliation></affiliation>
		<first_name_fa>Mehdi Forouzandeh-Moghadam</first_name_fa>
		<middle_name_fa></middle_name_fa>
		<last_name_fa></last_name_fa>
		<suffix_fa/>
		<email></email>
		<code></code>
		<coreauthor>No</coreauthor>
		<affiliation_fa></affiliation_fa>
	</author>
	</author_list>
</article>
</articleset></journal>
  